About iGenomX
iGenomX is a company based in San Diego (United States) founded in 2012 was acquired by Twist Bioscience in June 2021.. iGenomX has raised $5.13 million across 2 funding rounds from investors including Twist Bioscience. iGenomX operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and RareCyte, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Igenomx International Genomics Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.13 M (USD)
in 2 rounds
-
Latest Funding Round
$2.11 M (USD), Series A
Apr 23, 2019
- Investors
-
Employee Count
Employee Count
-
Acquired by
Twist Bioscience
(Jun 30, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iGenomX
iGenomX has successfully raised a total of $5.13M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.11 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.1M
-
First Round
First Round
(08 Dec 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series A - iGenomX | Valuation |
investors |
|
| Dec, 2015 | Amount | Series A - iGenomX | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in iGenomX
iGenomX has secured backing from 1 investor. Prominent investors backing the company include Twist Bioscience. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by iGenomX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - iGenomX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Igenomx Comparisons
Competitors of iGenomX
iGenomX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and RareCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Igenomx
Frequently Asked Questions about iGenomX
When was iGenomX founded?
iGenomX was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is iGenomX located?
iGenomX is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is iGenomX a funded company?
iGenomX is a funded company, having raised a total of $5.13M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.02M, raised on Dec 08, 2015.
What does iGenomX do?
iGenomX offers low-cost sample preparation technology capable of detecting all genetic variation. The tech was licensed from the laboratory of Dr. Daniel Salomon at the Scripps Research Institute. The low cost, fully automatable methodology centers around precisely controlling the polymerase enzyme to catalyze the formation of long-chain molecules by linking smaller molecular units, such as nucleotides with nucleic acids. This overcomes uncontrolled polymerization which causes amplification bias and error propagation, which leads to increased costs and reduced data quality.
Who are the top competitors of iGenomX?
iGenomX's top competitors include Abcam, Sino Biological and Paragon Genomics.
Who are iGenomX's investors?
iGenomX has 1 investor. Key investors include Twist Bioscience.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.